ReviewJournal of magnetic resonance imaging : JMRI2026
Evaluation of Living Liver Donors Using Dual-Contrast-Agent Magnetic Resonance Imaging (MRI) and Cholangiopancreatography (MRCP)-Technical Development.
Review in Journal of magnetic resonance imaging : JMRI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An Attention-Residual Hybrid CNN for CT-Based Multiclass Classification of Alcohol-Related Liver Disease: Differential Diagnosis Against HBV-Related Cirrhosis.Diagnostics (Basel, Switzerland) · 2026Article
- Evaluation of Living Liver Donors Using Dual-Contrast-Agent Magnetic Resonance Imaging (MRI) and Cholangiopancreatography (MRCP)-Technical Development.Journal of magnetic resonance imaging : JMRI · 2026Review
- Utility of DynamicBiomedicines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The indications for liver transplantation continue to expand to meet the growing need of patients with end-stage liver disease and select hepatic malignancies. Living donor liver transplantation allows for access to transplant with recipient outcomes superior to deceased donor liver transplantation. To ensure absolute safety of the donor and optimal outcome of the recipient, potential liver donors are subjected to an exhaustive preoperative evaluation. Radiological studies play a pivotal role in assessing the donor liver anatomy to assess suitability for donation and to facilitate surgical planning. Many living donor centers supplement single-agent contrast-enhanced MRCP (gadobenate dimeglumine or gadoxetate disodium) with contrast-enhanced CT angiography (CTA) for delineation of arterial anatomy. Excellent hepatic and portal venous mapping as well as biliary tract visualization has been seen, eliminating the need for CTA in studies. This review provides a case-based analysis of the proposed dual-contrast-enhanced MRCP protocol, emphasizing the advantages of a single diagnostic study over traditional multi-modality approaches while also discussing potential limitations and areas requiring further investigation. Evidence level: 4. Technical efficacy: Stage 1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.